Retraction of the letter: "Comment on 'CD4⁺ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy' ".

Autor: van der Most R; GlaxoSmithKline Vaccines, 1330 Rixensart, Belgium. GlaxoSmithKline Vaccines, King of Prussia, PA 19406, USA. robbert.x.van-der-most@gsk.com., Wettendorff M; GlaxoSmithKline Vaccines, 1330 Rixensart, Belgium. GlaxoSmithKline Vaccines, King of Prussia, PA 19406, USA., Innis B; GlaxoSmithKline Vaccines, 1330 Rixensart, Belgium. GlaxoSmithKline Vaccines, King of Prussia, PA 19406, USA., Hanon E; GlaxoSmithKline Vaccines, 1330 Rixensart, Belgium. GlaxoSmithKline Vaccines, King of Prussia, PA 19406, USA.
Jazyk: angličtina
Zdroj: Science translational medicine [Sci Transl Med] 2014 Sep 24; Vol. 6 (255), pp. 255rt2.
DOI: 10.1126/scitranslmed.3010397
Databáze: MEDLINE
Externí odkaz: